{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T21:02:13Z","timestamp":1794085333568,"version":"4.8.0"},"reference-count":282,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T00:00:00Z","timestamp":1646179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Acute lymphoblastic leukemia (ALL) is a heterogeneous group of hematologic malignancies characterized by abnormal proliferation of immature lymphoid cells. It is the most commonly diagnosed childhood cancer with an almost 80% cure rate. Despite favorable survival rates in the pediatric population, a significant number of patients develop resistance to therapy, resulting in poor prognosis. ALL is a heterogeneous disease at the genetic level, but the intensive development of sequencing in the last decade has made it possible to broaden the study of genomic changes. New technologies allow us to detect molecular changes such as point mutations or to characterize epigenetic or proteomic profiles. This process made it possible to identify new subtypes of this disease characterized by constellations of genetic alterations, including chromosome changes, sequence mutations, and DNA copy number alterations. These genetic abnormalities are used as diagnostic, prognostic and predictive biomarkers that play an important role in earlier disease detection, more accurate risk stratification, and treatment. Identification of new ALL biomarkers, and thus a greater understanding of their molecular basis, will lead to better monitoring of the course of the disease. In this article, we provide an overview of the latest information on genomic alterations found in childhood ALL and discuss their impact on patients\u2019 clinical outcomes.<\/jats:p>","DOI":"10.3390\/ijms23052755","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T08:37:16Z","timestamp":1646210236000},"page":"2755","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":72,"title":["Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8760-0775","authenticated-orcid":false,"given":"Monika","family":"Lejman","sequence":"first","affiliation":[{"name":"Laboratory of Genetic Diagnostics, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Cha\u0142upnik","sequence":"additional","affiliation":[{"name":"Student Scientific Society, Laboratory of Genetic Diagnostics, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8261-0192","authenticated-orcid":false,"given":"Zuzanna","family":"Chilimoniuk","sequence":"additional","affiliation":[{"name":"Student Scientific Society, Laboratory of Genetic Diagnostics, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Dobosz","sequence":"additional","affiliation":[{"name":"Student Scientific Society, Laboratory of Genetic Diagnostics, Medical University of Lublin, 20-093 Lublin, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,3,2]]},"reference":[{"key":"ref_1","first-page":"e82258","article-title":"Epidemiology, Incidence, and Mortality of Leukemia in Children Early Infancy to 14 Years Old of Age in South-Central Asia: A Global Ecological Study","volume":"10","author":"Khazaei","year":"2019","journal-title":"J. Compr. Pediatr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/sj.bjc.6605503","article-title":"Trends in Incidence of Childhood Cancer in Australia, 1983\u20132006","volume":"102","author":"Baade","year":"2010","journal-title":"Br. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/cncr.23169","article-title":"Trends in Childhood Cancer Incidence in the U.S. (1992\u20132004)","volume":"112","author":"Linabery","year":"2008","journal-title":"Cancer"},{"key":"ref_4","unstructured":"Ferlay, J., Ervik, M., Lam, F., Colombet, M., Mery, L., Pi\u00f1eros, M., Znaor, A., Soerjomataram, I., and Bray, F. (2022, January 06). Global Cancer Observatory: Cancer Today. Available online: http:\/\/gco.iarc.fr\/today\/home."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.31557\/APJCP.2020.21.5.1487","article-title":"GLOBAL Leukemia in Children 0\u201314 Statistics 2018, Incidence and Mortality and Human Development Index (HDI): GLOBOCAN Sources and Methods","volume":"21","author":"Namayandeh","year":"2020","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA","volume":"71","author":"Sung","year":"2021","journal-title":"Cancer J. Clin."},{"key":"ref_8","unstructured":"(2022, January 06). American Cancer Society Cancer Facts & Figures 2020. Available online: https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/cancer-facts-figures-2020.html."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","article-title":"Acute Lymphoblastic Leukaemia","volume":"395","author":"Malard","year":"2020","journal-title":"Lancet"},{"key":"ref_10","unstructured":"Howlader, N., Noone, A.M., Krapcho, M., Miller, D., Bishop, K., Kosary, C.L., Yu, M., Ruhl, J., Tatalovich, Z., and Mariotto, A. (2022, January 06). SEER Cancer Statistics Review, 1975\u20132014, Available online: https:\/\/seer.cancer.gov\/archive\/csr\/1975_2014\/#citation."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1200\/JCO.2011.37.8018","article-title":"Improved Survival for Children and Adolescents with Acute Lymphoblastic Leukemia between 1990 and 2005: A Report from the Children\u2019s Oncology Group","volume":"30","author":"Hunger","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1182\/blood-2008-06-164863","article-title":"Improvement in Survival in Younger Patients with Acute Lymphoblastic Leukemia from the 1980s to the Early 21st Century","volume":"113","author":"Pulte","year":"2009","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijheh.2018.08.004","article-title":"Household Exposure to Pesticides and Risk of Leukemia in Children and Adolescents: Updated Systematic Review and Meta-Analysis","volume":"222","author":"Lison","year":"2019","journal-title":"Int. J. Hyg. Environ. Health"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1667\/RR2892.1","article-title":"The Incidence of Leukemia, Lymphoma and Multiple Myeloma among Atomic Bomb Survivors: 1950\u20132001","volume":"179","author":"Hsu","year":"2013","journal-title":"Radiat. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/rpd\/ncn272","article-title":"Childhood Leukaemia Following Medical Diagnostic Exposure to Ionizing Radiation in Utero or after Birth","volume":"132","author":"Wakeford","year":"2008","journal-title":"Radiat. Prot. Dosim."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1038\/bjc.2013.614","article-title":"Leukaemia Incidence in the Techa River Cohort: 1953\u20132007","volume":"109","author":"Krestinina","year":"2013","journal-title":"Br. J. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.leukres.2011.01.023","article-title":"Numbers and Proportions of Leukemias in Young People and Adults Induced by Radiation of Natural Origin","volume":"35","author":"Kendall","year":"2011","journal-title":"Leuk. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrc1816","article-title":"Infection, Immune Responses and the Aetiology of Childhood Leukaemia","volume":"6","author":"Greaves","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(88)90867-7","article-title":"Evidence for an Infective Cause of Childhood Leukaemia: Comparison of a Scottish New Town with Nuclear Reprocessing Sites in Britain","volume":"2","author":"Kinlen","year":"1988","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"101193","DOI":"10.1016\/j.beha.2020.101193","article-title":"Molecular Markers in ALL: Clinical Implications","volume":"33","author":"Kimura","year":"2020","journal-title":"Best Pract. Res. Clin. Haematol."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Inaba, H., and Pui, C.-H. (2021). Advances in the Diagnosis and Treatment of Pediatric Acute Lymphoblastic Leukemia. J. Clin. Med., 10.","DOI":"10.3390\/jcm10091926"},{"key":"ref_22","first-page":"e2017310","article-title":"Leukemia Mortality Trends in Children and Adolescents in Brazilian State Capitals: 1980\u20132015","volume":"27","author":"Saraiva","year":"2018","journal-title":"Epidemiol. Serv. Saude Rev. Sist. Unico Saude Bras."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.3324\/haematol.2020.247031","article-title":"Pediatric Acute Lymphoblastic Leukemia","volume":"105","author":"Inaba","year":"2020","journal-title":"Haematology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1038\/ng.3301","article-title":"The Genomic Landscape of High Hyperdiploid Childhood Acute Lymphoblastic Leukemia","volume":"47","author":"Paulsson","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1136\/bmj.2.6151.1529","article-title":"Prognostic Implications of Chromosomal Findings in Acute Lymphoblastic Leukaemia at Diagnosis","volume":"2","author":"Lawler","year":"1978","journal-title":"BMJ"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/j.1365-2141.1989.tb07713.x","article-title":"Chromosomes and Other Prognostic Factors in Acute Lymphoblastic Leukaemia: A Long-Term Follow-Up","volume":"72","author":"Chessells","year":"1989","journal-title":"Br. J. Haematol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/sj.leu.2403673","article-title":"High Concordance from Independent Studies by the Children\u2019s Cancer Group (CCG) and Pediatric Oncology Group (POG) Associating Favorable Prognosis with Combined Trisomies 4, 10, and 17 in Children with NCI Standard-Risk B-Precursor Acute Lymphoblastic Leukemia: A Children\u2019s Oncology Group (COG) Initiative","volume":"19","author":"Sutcliffe","year":"2005","journal-title":"Leukemia"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S1470-2045(10)70066-8","article-title":"Prognostic Effect of Chromosomal Abnormalities in Childhood B-Cell Precursor Acute Lymphoblastic Leukaemia: Results from the UK Medical Research Council ALL97\/99 Randomised Trial","volume":"11","author":"Moorman","year":"2010","journal-title":"Lancet Oncol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1200\/JCO.2000.18.9.1876","article-title":"Prognostic Impact of Trisomies of Chromosomes 10, 17, and 5 Among Children With Acute Lymphoblastic Leukemia and High Hyperdiploidy (>50 Chromosomes)","volume":"18","author":"Heerema","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0165-4608(03)00272-3","article-title":"Is Trisomy 5 a Distinct Cytogenetic Subgroup in Acute Lymphoblastic Leukemia?","volume":"148","author":"Harris","year":"2004","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e828","DOI":"10.1016\/S2352-3026(21)00304-5","article-title":"Defining Low-Risk High Hyperdiploidy in Patients with Paediatric Acute Lymphoblastic Leukaemia: A Retrospective Analysis of Data from the UKALL97\/99 and UKALL2003 Clinical Trials","volume":"8","author":"Enshaei","year":"2021","journal-title":"Lancet Haematol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2401960","article-title":"Long-Term Results of Three Randomized Trials (58831, 58832, 58881) in Childhood Acute Lymphoblastic Leukemia: A CLCG-EORTC Report","volume":"14","author":"Vilmer","year":"2000","journal-title":"Leukemia"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1038\/sj.leu.2401965","article-title":"Long-Term Results of Treatment Studies for Childhood Acute Lymphoblastic Leukemia: Pediatric Oncology Group Studies from 1986\u20131994","volume":"14","author":"Maloney","year":"2000","journal-title":"Leukemia"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1038\/sj.leu.2401938","article-title":"Long-Term Results of Total Therapy Studies 11, 12 and 13A for Childhood Acute Lymphoblastic Leukemia at St Jude Children\u2019s Research Hospital","volume":"14","author":"Pui","year":"2000","journal-title":"Leukemia"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1182\/blood.V80.5.1316.1316","article-title":"Accumulation of High Levels of Methotrexate Polyglutamates in Lymphoblasts from Children with Hyperdiploid (Greater than 50 Chromosomes) B-Lineage Acute Lymphoblastic Leukemia: A Pediatric Oncology Group Study","volume":"80","author":"Whitehead","year":"1992","journal-title":"Blood"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0268-960X(03)00040-7","article-title":"Cytogenetics in Acute Leukemia","volume":"18","author":"Heerema","year":"2004","journal-title":"Blood Rev."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.clml.2012.04.004","article-title":"Clinical Cytogenetics in Pediatric Acute Leukemia: An Update","volume":"12","author":"Braoudaki","year":"2012","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/gcc.22956","article-title":"Single Nucleotide Polymorphism Array-based Signature of Low Hypodiploidy in Acute Lymphoblastic Leukemia","volume":"60","author":"Creasey","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1182\/blood-2016-10-743765","article-title":"Near-Haploid and Low-Hypodiploid Acute Lymphoblastic Leukemia: Two Distinct Subtypes with Consistently Poor Prognosis","volume":"129","author":"Safavi","year":"2017","journal-title":"Blood"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1111\/j.1365-2141.2004.04948.x","article-title":"Three Distinct Subgroups of Hypodiploidy in Acute Lymphoblastic Leukaemia: Hypodiploidy in ALL","volume":"125","author":"Harrison","year":"2004","journal-title":"Br. J. Haematol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1182\/blood-2006-10-051912","article-title":"Karyotype Is an Independent Prognostic Factor in Adult Acute Lymphoblastic Leukemia (ALL): Analysis of Cytogenetic Data from Patients Treated on the Medical Research Council (MRC) UKALLXII\/Eastern Cooperative Oncology Group (ECOG) 2993 Trial","volume":"109","author":"Moorman","year":"2007","journal-title":"Blood"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/ng.2532","article-title":"The Genomic Landscape of Hypodiploid Acute Lymphoblastic Leukemia","volume":"45","author":"Holmfeldt","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1182\/blood-2015-09-671131","article-title":"Outcome of Children with Hypodiploid ALL Treated with Risk-Directed Therapy Based on MRD Levels","volume":"126","author":"Mullighan","year":"2015","journal-title":"Blood"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"42793","DOI":"10.18632\/oncotarget.6000","article-title":"Genetic and Epigenetic Characterization of Hypodiploid Acute Lymphoblastic Leukemia","volume":"6","author":"Safavi","year":"2015","journal-title":"Oncotarget"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1182\/blood-2009-07-232124","article-title":"A Population-Based Cytogenetic Study of Adults with Acute Lymphoblastic Leukemia","volume":"115","author":"Moorman","year":"2010","journal-title":"Blood"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1200\/JCO.18.00884","article-title":"Hematopoietic Stem-Cell Transplantation Does Not Improve the Poor Outcome of Children with Hypodiploid Acute Lymphoblastic Leukemia: A Report from Children\u2019s Oncology Group","volume":"37","author":"McNeer","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1182\/hematology.2020000162","article-title":"What Is the Role for HSCT or Immunotherapy in Pediatric Hypodiploid B-Cell Acute Lymphoblastic Leukemia?","volume":"2020","author":"Talleur","year":"2020","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s12288-021-01409-w","article-title":"A Systematic Cytogenetic Strategy to Identify Masked Hypodiploidy in Precursor B Acute Lymphoblastic Leukemia in Low Resource Settings","volume":"37","author":"Gupta","year":"2021","journal-title":"Indian J. Hematol. Blood Transfus."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.cancergen.2019.07.009","article-title":"Masked Hypodiploidy: Hypodiploid Acute Lymphoblastic Leukemia (ALL) Mimicking Hyperdiploid ALL in Children: A Report from the Children\u2019s Oncology Group","volume":"238","author":"Carroll","year":"2019","journal-title":"Cancer Genet."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0165-4608(96)00351-2","article-title":"Acute Lymphoblastic Leukemia and Chromosome 21","volume":"94","author":"Berger","year":"1997","journal-title":"Cancer Genet. Cytogenet."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"On Behalf of the Medical Research Council Childhood and Adult Leukaemia Working Parties, Harewood, L., Robinson, H., Harris, R., Al-Obaidi, M.J., Jalali, G.R., Martineau, M., Moorman, A.V., Sumption, N., and Richards, S. (2003). Amplification of AML1 on a Duplicated Chromosome 21 in Acute Lymphoblastic Leukemia: A Study of 20 Cases. Leukemia, 17, 547\u2013553.","DOI":"10.1038\/sj.leu.2402849"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/leu.2013.317","article-title":"An International Study of Intrachromosomal Amplification of Chromosome 21 (IAMP21): Cytogenetic Characterization and Outcome","volume":"28","author":"Harrison","year":"2014","journal-title":"Leukemia"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cell.2010.11.055","article-title":"Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development","volume":"144","author":"Stephens","year":"2011","journal-title":"Cell"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1200\/JCO.2013.49.1308","article-title":"Intrachromosomal Amplification of Chromosome 21 Is Associated with Inferior Outcomes in Children with Acute Lymphoblastic Leukemia Treated in Contemporary Standard-Risk Children\u2019s Oncology Group Studies: A Report from the Children\u2019s Oncology Group","volume":"31","author":"Heerema","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/leu.2016.80","article-title":"The Role of the RAS Pathway in IAMP21-ALL","volume":"30","author":"Ryan","year":"2016","journal-title":"Leukemia"},{"key":"ref_56","first-page":"76","article-title":"Down Syndrome and Leukemia: Insights into Leukemogenesis and Translational Targets","volume":"4","author":"Mateos","year":"2015","journal-title":"Transl. Pediatr."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ejmg.2016.01.006","article-title":"Constitutional Abnormalities of Chromosome 21 Predispose to IAMP21-Acute Lymphoblastic Leukaemia","volume":"59","author":"Harrison","year":"2016","journal-title":"Eur. J. Med. Genet."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1179\/1024533215Z.000000000402","article-title":"Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia","volume":"20","author":"Forghieri","year":"2015","journal-title":"Hematology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s40880-016-0108-0","article-title":"The Philadelphia Chromosome in Leukemogenesis","volume":"35","author":"Kang","year":"2016","journal-title":"Chin. J. Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fonc.2014.00054","article-title":"Current Concepts in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia","volume":"4","author":"Bernt","year":"2014","journal-title":"Front. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature06866","article-title":"BCR-ABL1 Lymphoblastic Leukaemia Is Characterized by the Deletion of Ikaros","volume":"453","author":"Mullighan","year":"2008","journal-title":"Nature"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.3324\/haematol.2009.020792","article-title":"The PAX5 Gene Is Frequently Rearranged in BCR-ABL1-Positive Acute Lymphoblastic Leukemia but Is Not Associated with Outcome. A Report on Behalf of the GIMEMA Acute Leukemia Working Party","volume":"95","author":"Iacobucci","year":"2010","journal-title":"Haematologica"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nature09733","article-title":"Evolution of Human BCR\u2013ABL1 Lymphoblastic Leukaemia-Initiating Cells","volume":"469","author":"Notta","year":"2011","journal-title":"Nature"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13045-019-0729-2","article-title":"Treatment and Monitoring of Philadelphia Chromosome-Positive Leukemia Patients: Recent Advances and Remaining Challenges","volume":"12","author":"Soverini","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJM200004063421402","article-title":"Outcome of Treatment in Children with Philadelphia Chromosome\u2013Positive Acute Lymphoblastic Leukemia","volume":"342","author":"Valsecchi","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.1200\/JCO.2010.30.1325","article-title":"Clinical Outcome of Children with Newly Diagnosed Philadelphia Chromosome\u2013Positive Acute Lymphoblastic Leukemia Treated Between 1995 and 2005","volume":"28","author":"Schrappe","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_68","unstructured":"(2022, January 29). Paper: Multicenter Total Therapy Gimema LAL 1509 Protocol for De Novo Adult Ph+ Acute Lymphoblastic Leukemia (ALL) Patients. Updated Results and Refined Genetic-Based Prognostic Stratification. Available online: https:\/\/ash.confex.com\/ash\/2015\/webprogramscheduler\/Paper84424.html."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"From the Children\u2019s Oncology Group, Schultz, K.R., Carroll, A., Heerema, N.A., Bowman, W.P., Aledo, A., Slayton, W.B., Sather, H., Devidas, M., and Zheng, H.W. (2014). Long-Term Follow-up of Imatinib in Pediatric Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Children\u2019s Oncology Group Study AALL0031. Leukemia, 28, 1467\u20131471.","DOI":"10.1038\/leu.2014.30"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1200\/JCO.2008.21.6408","article-title":"IKZF1 (Ikaros) Deletions in BCR-ABL1 \u2013Positive Acute Lymphoblastic Leukemia Are Associated with Short Disease-Free Survival and High Rate of Cumulative Incidence of Relapse: A GIMEMA AL WP Report","volume":"27","author":"Martinelli","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1101\/gad.1673908","article-title":"Failure of CDKN2A\/B (INK4A\/B\u2013ARF)-Mediated Tumor Suppression and Resistance to Targeted Therapy in Acute Lymphoblastic Leukemia Induced by BCR-ABL","volume":"22","author":"Mullighan","year":"2008","journal-title":"Genes Dev."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"The Children\u2019s Oncology Group, Schultz, K.R., Devidas, M., Bowman, W.P., Aledo, A., Slayton, W.B., Sather, H., Zheng, H.W., Davies, S.M., and Gaynon, P.S. (2014). Philadelphia Chromosome-Negative Very High-Risk Acute Lymphoblastic Leukemia in Children and Adolescents: Results from Children\u2019s Oncology Group Study AALL0031. Leukemia, 28, 964\u2013967.","DOI":"10.1038\/leu.2014.29"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S1470-2045(12)70377-7","article-title":"Imatinib after Induction for Treatment of Children and Adolescents with Philadelphia-Chromosome-Positive Acute Lymphoblastic Leukaemia (EsPhALL): A Randomised, Open-Label, Intergroup Study","volume":"13","author":"Biondi","year":"2012","journal-title":"Lancet Oncol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1365-2141.2012.09039.x","article-title":"Imatinib Resistant BCR-ABL1 Mutations at Relapse in Children with Ph+ ALL: A Children\u2019s Oncology Group (COG) Study","volume":"157","author":"Chang","year":"2012","journal-title":"Br. J. Haematol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"632231","DOI":"10.3389\/fonc.2021.632231","article-title":"Dasatinib in the Management of Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia","volume":"11","author":"Cerchione","year":"2021","journal-title":"Front. Oncol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11864-019-0603-z","article-title":"Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia","volume":"20","author":"Jabbour","year":"2019","journal-title":"Curr. Treat. Options Oncol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"150","DOI":"10.5858\/arpa.2019-0194-RA","article-title":"BCR-ABL1\u2013like B-Acute Lymphoblastic Leukemia\/Lymphoma: A Comprehensive Review","volume":"144","author":"Jain","year":"2020","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMc090454","article-title":"Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia","volume":"360","author":"Medeiros","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"e354","DOI":"10.3324\/haematol.2015.124941","article-title":"BCR-ABL1-like Cases in Pediatric Acute Lymphoblastic Leukemia: A Comparison between DCOG\/Erasmus MC and COG\/St. Jude Signatures","volume":"100","author":"Boer","year":"2015","journal-title":"Haematologica"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1470-2045(08)70339-5","article-title":"A Subtype of Childhood Acute Lymphoblastic Leukaemia with Poor Treatment Outcome: A Genome-Wide Classification Study","volume":"10","author":"Cheok","year":"2009","journal-title":"Lancet Oncol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1056\/NEJMoa0808253","article-title":"Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia","volume":"360","author":"Mullighan","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1159\/000456572","article-title":"The Genomic Landscape of PAX5, IKZF1, and CDKN2A\/B Alterations in B-Cell Precursor Acute Lymphoblastic Leukemia","volume":"150","author":"Ou","year":"2016","journal-title":"Cytogenet Genome Res."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/cncr.31848","article-title":"BCR\/ABL1-like Acute Lymphoblastic Leukemia: How to Diagnose and Treat? Open Questions in BCR\/ABL1-Like ALL","volume":"125","author":"Chiaretti","year":"2019","journal-title":"Cancer"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1182\/blood-2018-04-841676","article-title":"Genomic and Outcome Analyses of Ph-like ALL in NCI Standard-Risk Patients: A Report from the Children\u2019s Oncology Group","volume":"132","author":"Roberts","year":"2018","journal-title":"Blood"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Xu, H., Yu, H., Jin, R., Wu, X., and Chen, H. (2021). Genetic and Epigenetic Targeting Therapy for Pediatric Acute Lymphoblastic Leukemia. Cells, 10.","DOI":"10.3390\/cells10123349"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1200\/JCO.2016.69.0073","article-title":"High Frequency and Poor Outcome of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Adults","volume":"35","author":"Roberts","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nrclinonc.2015.38","article-title":"Genomics in Acute Lymphoblastic Leukaemia: Insights and Treatment Implications","volume":"12","author":"Roberts","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1200\/JCO.2014.55.4105","article-title":"Outcomes of Children with BCR-ABL1-Like Acute Lymphoblastic Leukemia Treated with Risk-Directed Therapy Based on the Levels of Minimal Residual Disease","volume":"32","author":"Roberts","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"e490","DOI":"10.3324\/haematol.2016.162925","article-title":"High Prevalence of Relapse in Children with Philadelphia-like Acute Lymphoblastic Leukemia despite Risk-Adapted Treatment","volume":"102","author":"Heatley","year":"2017","journal-title":"Haematologica"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2018-10-881961","article-title":"A Pediatric Regimen for Older Adolescents and Young Adults with Acute Lymphoblastic Leukemia: Results of CALGB 10403","volume":"133","author":"Stock","year":"2019","journal-title":"Blood"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"5290","DOI":"10.1182\/blood-2018-99-113471","article-title":"Poor Outcome of CRLF2 Rearranged Philadelphia Negative Acute Lymphoblastic Leukemia Adults Patients","volume":"132","author":"Elnahass","year":"2018","journal-title":"Blood"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/j.1365-2141.2012.09221.x","article-title":"Treatment Outcome of CRLF2-Rearranged Childhood Acute Lymphoblastic Leukaemia: A Comparative Analysis of the AIEOP-BFM and UK NCRI-CCLG Study Groups","volume":"158","author":"Attarbaschi","year":"2012","journal-title":"Br. J. Haematol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"49722","DOI":"10.18632\/oncotarget.10437","article-title":"High CRLF2 Expression Associates with IKZF1 Dysfunction in Adult Acute Lymphoblastic Leukemia without CRLF2 Rearrangement","volume":"7","author":"Ge","year":"2016","journal-title":"Oncotarget"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ccell.2015.12.013","article-title":"Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia","volume":"29","author":"Iacobucci","year":"2016","journal-title":"Cancer Cell"},{"key":"ref_95","first-page":"1657","article-title":"Oncogenic Role and Therapeutic Targeting of ABL-Class and JAK-STAT Activating Kinase Alterations in Ph-like ALL","volume":"1","author":"Roberts","year":"2017","journal-title":"Blood Adv."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/pbc.25327","article-title":"TKI Dasatinib Monotherapy for a Patient with Ph-like ALL Bearing ATF7IP\/PDGFRB Translocation: TKI Dasatinib Monotherapy for Ph-like ALL Bearing PDGFRB Translocation","volume":"62","author":"Kobayashi","year":"2015","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.12659\/AJCR.906300","article-title":"Acute Lymphoblastic Leukemia Patient with Variant ATF7IP\/PDGFRB Fusion and Favorable Response to Tyrosine Kinase Inhibitor Treatment: A Case Report","volume":"18","author":"Zhang","year":"2017","journal-title":"Am. J. Case Rep."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1073\/pnas.0811761106","article-title":"JAK Mutations in High-Risk Childhood Acute Lymphoblastic Leukemia","volume":"106","author":"Mullighan","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1182\/blood-2016-12-758979","article-title":"Targetable Kinase Gene Fusions in High-Risk B-ALL: A Study from the Children\u2019s Oncology Group","volume":"129","author":"Reshmi","year":"2017","journal-title":"Blood"},{"key":"ref_100","unstructured":"AdisInsight (2022, January 29). A Phase 2 Study of the JAK1\/JAK2 Inhibitor Ruxolitinib with Chemotherapy in Children with De Novo High-Risk CRLF2-Rearranged and\/or JAK Pathway-Mutant Acute Lymphoblastic Leukemia. Available online: https:\/\/adisinsight.springer.com\/trials\/700267573."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1182\/blood-2018-05-849554","article-title":"ETV6-NTRK3 Induces Aggressive Acute Lymphoblastic Leukemia Highly Sensitive to Selective TRK Inhibition","volume":"132","author":"Roberts","year":"2018","journal-title":"Blood"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.clml.2020.08.011","article-title":"Philadelphia-Like Acute Lymphoblastic Leukemia: A Systematic Review","volume":"21","author":"Yadav","year":"2021","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1200\/JCO.2016.69.3531","article-title":"Complete Hematologic and Molecular Response in Adult Patients with Relapsed\/Refractory Philadelphia Chromosome\u2013Positive B-Precursor Acute Lymphoblastic Leukemia Following Treatment with Blinatumomab: Results from a Phase II, Single-Arm, Multicenter Study","volume":"35","author":"Martinelli","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJMoa1609783","article-title":"Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia","volume":"376","author":"Kantarjian","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1182\/blood.2019001244","article-title":"Efficacy of Tyrosine Kinase Inhibitors in Ph-like Acute Lymphoblastic Leukemia Harboring ABL-Class Rearrangements","volume":"134","author":"Tanasi","year":"2019","journal-title":"Blood"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1182\/bloodadvances.2019001416","article-title":"Cotargeting BCL-2 and MCL-1 in High-Risk B-ALL","volume":"4","author":"Moujalled","year":"2020","journal-title":"Blood Adv."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1046\/j.1365-2141.1996.d01-1748.x","article-title":"Exon\/Intron Structure of the Human ALL-1 (MLL) Gene Involved in Translocations to Chromosomal Region 11q23 and Acute Leukaemias","volume":"93","author":"Nilson","year":"1996","journal-title":"Br. J. Haematol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11899-020-00582-5","article-title":"MLL-Rearranged Acute Lymphoblastic Leukemia","volume":"15","author":"Keng","year":"2020","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1182\/blood-2010-03-273532","article-title":"Improved Outcome with Hematopoietic Stem Cell Transplantation in a Poor Prognostic Subgroup of Infants with Mixed-Lineage-Leukemia (MLL)\u2013Rearranged Acute Lymphoblastic Leukemia: Results from the Interfant-99 Study","volume":"116","author":"Mann","year":"2010","journal-title":"Blood"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/363358a0","article-title":"In Utero Rearrangements in the Trithorax-Related Oncogene in Infant Leukaemias","volume":"363","author":"Ford","year":"1993","journal-title":"Nature"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/ajcp\/111.4.467","article-title":"Acute Lymphoblastic Leukemia: Survey of Immunophenotype, French-American-British Classification, Frequency of Myeloid Antigen Expression, and Karyotypic Abnormalities in 210 Pediatric and Adult Cases","volume":"111","author":"Khalidi","year":"1999","journal-title":"Am. J. Clin. Pathol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1200\/JCO.1998.16.12.3768","article-title":"Reappraisal of the Clinical and Biologic Significance of Myeloid-Associated Antigen Expression in Childhood Acute Lymphoblastic Leukemia","volume":"16","author":"Pui","year":"1998","journal-title":"J. Clin. Oncol."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/leu.2017.213","article-title":"The MLL Recombinome of Acute Leukemias in 2017","volume":"32","author":"Meyer","year":"2018","journal-title":"Leukemia"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/fped.2017.00004","article-title":"MLL-Rearranged Leukemias\u2014An Update on Science and Clinical Approaches","volume":"5","author":"Winters","year":"2017","journal-title":"Front. Pediatr."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1016\/S0140-6736(02)08782-2","article-title":"Outcome of Treatment in Childhood Acute Lymphoblastic Leukaemia with Rearrangements of the 11q23 Chromosomal Region","volume":"359","author":"Pui","year":"2002","journal-title":"Lancet"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1038\/leu.2013.135","article-title":"The MLL Recombinome of Acute Leukemias in 2013","volume":"27","author":"Meyer","year":"2013","journal-title":"Leukemia"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/bjh.12250","article-title":"The distribution of MLL breakpoints correlates with outcome in infant acute leukaemia","volume":"161","author":"Emerenciano","year":"2013","journal-title":"Br. J. Haematol."},{"key":"ref_118","doi-asserted-by":"crossref","unstructured":"Zerkalenkova, E., Lebedeva, S., Borkovskaia, A., Soldatkina, O., Plekhanova, O., Tsaur, G., Maschan, M., Maschan, A., Novichkova, G., and Olshanskaya, Y. (2021). BTK, NUTM2A, and PRPF19 Are Novel KMT2A Partner Genes in Childhood Acute Leukemia. Biomedicines, 9.","DOI":"10.3390\/biomedicines9080924"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1200\/JCO.2005.05.047","article-title":"Molecular Genetics of Acute Lymphoblastic Leukemia","volume":"23","author":"Armstrong","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1056\/NEJMra1400972","article-title":"Acute Lymphoblastic Leukemia in Children","volume":"373","author":"Hunger","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/j.leukres.2008.03.018","article-title":"Clinical Features and Outcome of MLL Gene Rearranged Acute Lymphoblastic Leukemia in Infants with Additional Chromosomal Abnormalities Other than 11q23 Translocation","volume":"32","author":"Tauchi","year":"2008","journal-title":"Leuk. Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bcmd.2007.07.005","article-title":"Insights from Clinical Studies into the Role of the MLL Gene in Infant and Childhood Leukemia","volume":"40","author":"Chowdhury","year":"2008","journal-title":"Blood Cells Mol. Dis."},{"key":"ref_123","doi-asserted-by":"crossref","unstructured":"For the St. Jude Children\u2019s Research Hospital\u2013Washington University Pediatric Cancer Genome Project, Andersson, A.K., Ma, J., Wang, J., Chen, X., Gedman, A.L., Dang, J., Nakitandwe, J., Holmfeldt, L., and Parker, M. (2015). The Landscape of Somatic Mutations in Infant MLL-Rearranged Acute Lymphoblastic Leukemias. Nat. Genet., 47, 330\u2013337.","DOI":"10.1038\/ng.3230"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.3324\/haematol.2018.206375","article-title":"Unraveling the Cellular Origin and Clinical Prognostic Markers of Infant B-Cell Acute Lymphoblastic Leukemia Using Genome-Wide Analysis","volume":"104","author":"Bueno","year":"2019","journal-title":"Haematologica"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1038\/s41467-018-04180-1","article-title":"De Novo Activating Mutations Drive Clonal Evolution and Enhance Clonal Fitness in KMT2A-Rearranged Leukemia","volume":"9","author":"Pilheden","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nm.3832","article-title":"DOT1L Inhibits SIRT1-Mediated Epigenetic Silencing to Maintain Leukemic Gene Expression in MLL-Rearranged Leukemia","volume":"21","author":"Chen","year":"2015","journal-title":"Nat. Med."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s11684-020-0759-8","article-title":"Precision medicine in acute lymphoblastic leukemia","volume":"14","author":"Pui","year":"2020","journal-title":"Front. Med."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.3389\/fonc.2019.01496","article-title":"Drug Resistance Biomarkers and Their Clinical Applications in Childhood Acute Lymphoblastic Leukemia","volume":"9","author":"Aberuyi","year":"2020","journal-title":"Front. Oncol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev.immunol.20.092501.162048","article-title":"E Protein Function in Lymphocyte Development","volume":"20","author":"Quong","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41588-018-0315-5","article-title":"PAX5-Driven Subtypes of B-Progenitor Acute Lymphoblastic Leukemia","volume":"51","author":"Gu","year":"2019","journal-title":"Nat. Genet."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1038\/leu.2009.42","article-title":"Increased Risk for CNS Relapse in Pre-B Cell Leukemia with the t(1;19)\/TCF3-PBX1","volume":"23","author":"Jeha","year":"2009","journal-title":"Leukemia"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.3109\/10428194.2011.565436","article-title":"Prognostic Impact of t(1;19)\/TCF3\u2013PBX1 in Childhood Acute Lymphoblastic Leukemia in the Context of Berlin\u2013Frankfurt\u2013M\u00fcnster-Based Protocols","volume":"52","author":"Felice","year":"2011","journal-title":"Leuk. Lymphoma"},{"key":"ref_133","doi-asserted-by":"crossref","unstructured":"Vora, A. (2017). Cytogenetics and Molecular Genetics. Childhood Acute Lymphoblastic Leukemia, Springer International Publishing.","DOI":"10.1007\/978-3-319-39708-5"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.1038\/sj.onc.1208568","article-title":"Inhibition of Wnt16 in Human Acute Lymphoblastoid Leukemia Cells Containing the t(1;19) Translocation Induces Apoptosis","volume":"24","author":"Mazieres","year":"2005","journal-title":"Oncogene"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.ccr.2012.08.027","article-title":"Crosstalk between ROR1 and the Pre-B Cell Receptor Promotes Survival of t(1;19) Acute Lymphoblastic Leukemia","volume":"22","author":"Bicocca","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1172\/JCI83535","article-title":"Wnt5a Induces ROR1\/ROR2 Heterooligomerization to Enhance Leukemia Chemotaxis and Proliferation","volume":"126","author":"Yu","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1158\/1078-0432.CCR-15-0154","article-title":"Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia","volume":"22","author":"Janovska","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1038\/s41388-018-0670-9","article-title":"Wnt5a and ROR1 Activate Non-Canonical Wnt Signaling via RhoA in TCF3-PBX1 Acute Lymphoblastic Leukemia and Highlight New Treatment Strategies via Bcl-2 Co-Targeting","volume":"38","author":"Karvonen","year":"2019","journal-title":"Oncogene"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1172\/JCI81158","article-title":"Comparative Genomics Reveals Multistep Pathogenesis of E2A-PBX1 Acute Lymphoblastic Leukemia","volume":"125","author":"Feng","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.1128\/MCB.18.10.6035","article-title":"The AD1 and AD2 Transactivation Domains of E2A Are Essential for the Antiapoptotic Activity of the Chimeric Oncoprotein E2A-HLF","volume":"18","author":"Inukai","year":"1998","journal-title":"Mol. Cell Biol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/sj.leu.2404496","article-title":"Hypercalcemia in Childhood Acute Lymphoblastic Leukemia: Frequent Implication of Parathyroid Hormone-Related Peptide and E2A-HLF from Translocation 17;19","volume":"21","author":"Inukai","year":"2007","journal-title":"Leukemia"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1182\/blood.V83.10.2970.2970","article-title":"Two Types of Genomic Rearrangements Create Alternative E2A-HLF Fusion Proteins in t(17;19)-ALL","volume":"83","author":"Hunger","year":"1994","journal-title":"Blood"},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1535-6108(02)00155-1","article-title":"Slug, a Highly Conserved Zinc Finger Transcriptional Repressor, Protects Hematopoietic Progenitor Cells from Radiation-Induced Apoptosis in Vivo","volume":"2","author":"Inoue","year":"2002","journal-title":"Cancer Cell"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1097-2765(00)80336-6","article-title":"SLUG, a Ces-1-Related Zinc Finger Transcription Factor Gene with Antiapoptotic Activity, Is a Downstream Target of the E2A-HLF Oncoprotein","volume":"4","author":"Inukai","year":"1999","journal-title":"Mol. Cell"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1038\/ng.3362","article-title":"Genomics and Drug Profiling of Fatal TCF3-HLF-Positive Acute Lymphoblastic Leukemia Identifies Recurrent Mutation Patterns and Therapeutic Options","volume":"47","author":"Fischer","year":"2015","journal-title":"Nat. Genet."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.clml.2021.01.014","article-title":"Successful Treatment of TCF3-HLF\u2013Positive Childhood B-ALL with Chimeric Antigen Receptor T-Cell Therapy","volume":"21","author":"Wang","year":"2021","journal-title":"Clin. Lymphoma Myeloma Leuk."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMra023001","article-title":"Acute Lymphoblastic Leukemia","volume":"350","author":"Pui","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-981-10-3233-2_13","article-title":"Mechanism of ETV6-RUNX1 Leukemia","volume":"Volume 962","author":"Groner","year":"2017","journal-title":"RUNX Proteins in Development and Cancer"},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"4263","DOI":"10.1182\/blood.V86.11.4263.bloodjournal86114263","article-title":"High frequency of t(12;21) in childhood B-lineage acute lymphoblastic leukemia","volume":"86","author":"Romana","year":"1995","journal-title":"Blood"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1146\/annurev.biochem.79.081507.103945","article-title":"Genomic and Biochemical Insights into the Specificity of ETS Transcription Factors","volume":"80","author":"Hollenhorst","year":"2011","journal-title":"Annu. Rev. Biochem."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00062752-200207000-00013","article-title":"TEL\/AML1-Positive Pediatric Leukemia: Prognostic Significance and Therapeutic Approaches","volume":"9","author":"Loh","year":"2002","journal-title":"Curr. Opin. Hematol."},{"key":"ref_152","first-page":"6336","article-title":"Identification of AML-1 and the (8;21) Translocation Protein (AML-1\/ETO) as Sequence-Specific DNA-Binding Proteins: The Runt Homology Domain Is Required for DNA Binding and Protein-Protein Interactions","volume":"13","author":"Meyers","year":"1993","journal-title":"Mol. Cell Biol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0092-8674(00)80986-1","article-title":"AML1, the Target of Multiple Chromosomal Translocations in Human Leukemia, Is Essential for Normal Fetal Liver Hematopoiesis","volume":"84","author":"Okuda","year":"1996","journal-title":"Cell"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/S0140-6736(99)09403-9","article-title":"Prenatal Origin of Acute Lymphoblastic Leukaemia in Children","volume":"354","author":"Wiemels","year":"1999","journal-title":"Lancet"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1182\/blood-2017-09-808402","article-title":"Five Percent of Healthy Newborns Have an ETV6-RUNX1 Fusion as Revealed by DNA-Based GIPFEL Screening","volume":"131","author":"Olsen","year":"2018","journal-title":"Blood"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature05690","article-title":"Genome-Wide Analysis of Genetic Alterations in Acute Lymphoblastic Leukaemia","volume":"446","author":"Mullighan","year":"2007","journal-title":"Nature"},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ng.2874","article-title":"RAG-Mediated Recombination Is the Predominant Driver of Oncogenic Rearrangement in ETV6-RUNX1 Acute Lymphoblastic Leukemia","volume":"46","author":"Papaemmanuil","year":"2014","journal-title":"Nat. Genet."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/sj.leu.2404691","article-title":"High-Resolution Genomic Profiling of Childhood ALL Reveals Novel Recurrent Genetic Lesions Affecting Pathways Involved in Lymphocyte Differentiation and Cell Cycle Progression","volume":"21","author":"Kuiper","year":"2007","journal-title":"Leukemia"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1038\/sj.leu.2400798","article-title":"ETV6 Is the Target of Chromosome 12p Deletions in t(12;21) Childhood Acute Lymphocytic Leukemia","volume":"11","author":"Cacheux","year":"1997","journal-title":"Leukemia"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1182\/blood.V87.7.2891.bloodjournal8772891","article-title":"The 12;21 translocation involving TEL and deletion of the other TEL allele: Two frequently associated alterations found in childhood acute lymphoblastic leukemia","volume":"87","author":"Raynaud","year":"1996","journal-title":"Blood"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/sj.leu.2404083","article-title":"Incidence of Additional Genetic Changes in the TEL and AML1 Genes in DCOG and COALL-Treated t(12;21)-Positive Pediatric ALL, and Their Relation with Drug Sensitivity and Clinical Outcome","volume":"20","author":"Stams","year":"2006","journal-title":"Leukemia"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1600-0609.2009.01315.x","article-title":"Interphase FISH on TEL\/AML1 Positive Acute Lymphoblastic Leukemia Relapses\u2014Analysis of Clinical Relevance of Additional TEL and AML1 Copy Number Changes","volume":"83","author":"Peter","year":"2009","journal-title":"Eur. J. Haematol."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/sj.leu.2403471","article-title":"Austrian Berlin-Frankfurt-M\u00fcnster cooperative study group Incidence and Relevance of Secondary Chromosome Abnormalities in Childhood TEL\/AML1+ Acute Lymphoblastic Leukemia: An Interphase FISH Analysis","volume":"18","author":"Attarbaschi","year":"2004","journal-title":"Leukemia"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/(SICI)1098-2264(199903)24:3<272::AID-GCC13>3.0.CO;2-U","article-title":"Trisomy 21 Is a Recurrent Secondary Aberration in Childhood Acute Lymphoblastic Leukemia with TEL\/AML1 Gene Fusion","volume":"24","author":"Loncarevic","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.arcmed.2016.12.002","article-title":"Copy Number Alterations Associated with Acute Lymphoblastic Leukemia in Mexican Children. A Report from The Mexican Inter-Institutional Group for the Identification of the Causes of Childhood Leukemia","volume":"47","year":"2016","journal-title":"Arch. Med. Res."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1158\/0008-5472.CAN-17-0701","article-title":"Infection Exposure Promotes ETV6-RUNX1 Precursor B-Cell Leukemia via Impaired H3K4 Demethylases","volume":"77","author":"Hauer","year":"2017","journal-title":"Cancer Res."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/leu.2011.227","article-title":"ETV6-RUNX1-Positive Childhood Acute Lymphoblastic Leukemia: Improved Outcome with Contemporary Therapy","volume":"26","author":"Bhojwani","year":"2012","journal-title":"Leukemia"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2141.2008.06980.x","article-title":"Outcome of ETV6\/RUNX1-Positive Childhood Acute Lymphoblastic Leukaemia in the NOPHO-ALL-1992 Protocol: Frequent Late Relapses but Good Overall Survival","volume":"140","author":"Forestier","year":"2008","journal-title":"Br. J. Haematol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.3324\/haematol.2011.059584","article-title":"Excellent Prognosis of Late Relapses of ETV6\/RUNX1-Positive Childhood Acute Lymphoblastic Leukemia: Lessons from the FRALLE 93 Protocol","volume":"97","author":"Gandemer","year":"2012","journal-title":"Haematologica"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/leu.2016.274","article-title":"Long-Term Outcome of 6-Month Maintenance Chemotherapy for Acute Lymphoblastic Leukemia in Children","volume":"31","author":"Kato","year":"2017","journal-title":"Leukemia"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s12185-019-02599-w","article-title":"Discontinuation of L-Asparaginase and Poor Response to Prednisolone Are Associated with Poor Outcome of ETV6-RUNX1-Positive Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia","volume":"109","author":"Usami","year":"2019","journal-title":"Int. J. Hematol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/leu.2016.234","article-title":"Clinical Impact of Minimal Residual Disease in Children with Different Subtypes of Acute Lymphoblastic Leukemia Treated with Response-Adapted Therapy","volume":"31","author":"Pui","year":"2017","journal-title":"Leukemia"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1200\/JCO.2017.74.0449","article-title":"Genotype-Specific Minimal Residual Disease Interpretation Improves Stratification in Pediatric Acute Lymphoblastic Leukemia","volume":"36","author":"Enshaei","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13052-018-0541-6","article-title":"ETV6\/RUNX1-Positive Childhood Acute Lymphoblastic Leukemia in China: Excellent Prognosis with Improved BFM Protocol","volume":"44","author":"Wang","year":"2018","journal-title":"Ital. J. Pediatr."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/gcc.22464","article-title":"ETV6\/RUNX1-like Acute Lymphoblastic Leukemia: A Novel B-Cell Precursor Leukemia Subtype Associated with the CD27\/CD44 Immunophenotype","volume":"56","author":"Zaliova","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"11790","DOI":"10.1038\/ncomms11790","article-title":"Identification of ETV6-RUNX1-like and DUX4-Rearranged Subtypes in Paediatric B-Cell Precursor Acute Lymphoblastic Leukaemia","volume":"7","author":"Henningsson","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11684-020-0821-6","article-title":"Emerging Molecular Subtypes and Therapeutic Targets in B-Cell Precursor Acute Lymphoblastic Leukemia","volume":"15","author":"Li","year":"2021","journal-title":"Front. Med."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"E11711","DOI":"10.1073\/pnas.1814397115","article-title":"Transcriptional Landscape of B Cell Precursor Acute Lymphoblastic Leukemia Based on an International Study of 1,223 Cases","volume":"115","author":"Li","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1182\/blood-2017-05-742643","article-title":"New Oncogenic Subtypes in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia","volume":"130","author":"Fioretos","year":"2017","journal-title":"Blood"},{"key":"ref_180","doi-asserted-by":"crossref","unstructured":"Lee, S.H.R., Li, Z., Tai, S.T., Oh, B.L.Z., and Yeoh, A.E.J. (2021). Genetic Alterations in Childhood Acute Lymphoblastic Leukemia: Interactions with Clinical Features and Treatment Response. Cancers, 13.","DOI":"10.3390\/cancers13164068"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/2643-3230.BCD-20-0229","article-title":"Clinical Significance of Novel Subtypes of Acute Lymphoblastic Leukemia in the Context of Minimal Residual Disease-Directed Therapy","volume":"2","author":"Jeha","year":"2021","journal-title":"Blood Cancer Discov."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"e351","DOI":"10.1097\/MPH.0000000000001976","article-title":"Common Variable Immunodeficiency, Autoimmune Hemolytic Anemia, and Pancytopenia Associated with a Defect in IKAROS","volume":"43","author":"Yilmaz","year":"2021","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0092-8674(94)90407-3","article-title":"The Ikaros Gene Is Required for the Development of All Lymphoid Lineages","volume":"79","author":"Georgopoulos","year":"1994","journal-title":"Cell"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1126\/science.1439790","article-title":"Ikaros, an Early Lymphoid-Specific Transcription Factor and a Putative Mediator for T Cell Commitment","volume":"258","author":"Georgopoulos","year":"1992","journal-title":"Science"},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2017.11.005","article-title":"The Ikaros Family in Lymphocyte Development","volume":"51","author":"Heizmann","year":"2018","journal-title":"Curr. Opin. Immunol."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"53","DOI":"10.18176\/jiaci.0207","article-title":"B-Cell Deficiency: A De Novo IKZF1 Patient and Review of the Literature","volume":"28","author":"Chen","year":"2018","journal-title":"J. Investig. Allergol. Clin. Immunol."},{"key":"ref_187","doi-asserted-by":"crossref","unstructured":"On Behalf of the EORTC-CLG, Clappier, E., Grardel, N., Bakkus, M., Rapion, J., De Moerloose, B., Kastner, P., Caye, A., Vivent, J., and Costa, V. (2015). IKZF1 Deletion Is an Independent Prognostic Marker in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia, and Distinguishes Patients Benefiting from Pulses during Maintenance Therapy: Results of the EORTC Children\u2019s Leukemia Group Study 58951. Leukemia, 29, 2154\u20132161.","DOI":"10.1038\/leu.2015.134"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1182\/blood.V126.23.2613.2613","article-title":"Ikaros Gene Deletion Significantly Predicts Relapse in Pediatric B-ALL Patients with Low End-Induction Minimal Residual Disease","volume":"126","author":"Harris","year":"2015","journal-title":"Blood"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1182\/blood-2012-10-462358","article-title":"Independent Prognostic Value of BCR-ABL1-like Signature and IKZF1 Deletion, but Not High CRLF2 Expression, in Children with B-Cell Precursor ALL","volume":"122","author":"Waanders","year":"2013","journal-title":"Blood"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/nri3550","article-title":"Two Versions of the Ikaros Tale","volume":"13","author":"Papatriantafyllou","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1159\/000069438","article-title":"Lack of Natural Killer Cell Precursors in Fetal Liver of Ikaros Knockout Mutant Mice","volume":"16","author":"Boggs","year":"1998","journal-title":"Nat. Immun."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/ni.2821","article-title":"Loss of Ikaros DNA-Binding Function Confers Integrin-Dependent Survival on Pre-B Cells and Progression to Acute Lymphoblastic Leukemia","volume":"15","author":"Joshi","year":"2014","journal-title":"Nat. Immunol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood-2008-08-173963","article-title":"Identification and Molecular Characterization of Recurrent Genomic Deletions on 7p12 in the IKZF1 Gene in a Large Cohort of BCR-ABL1\u2013Positive Acute Lymphoblastic Leukemia Patients: On Behalf of Gruppo Italiano Malattie Ematologiche Dell\u2019Adulto Acute Leukemia Working Party (GIMEMA AL WP)","volume":"114","author":"Iacobucci","year":"2009","journal-title":"Blood"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/leu.2015.199","article-title":"Prognostic Value of Rare IKZF1 Deletion in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia: An International Collaborative Study","volume":"30","author":"Boer","year":"2016","journal-title":"Leukemia"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1084\/jem.20090004","article-title":"Pre\u2013B Cell Receptor\u2013Mediated Cell Cycle Arrest in Philadelphia Chromosome\u2013Positive Acute Lymphoblastic Leukemia Requires IKAROS Function","volume":"206","author":"Trageser","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3324\/haematol.2017.185603","article-title":"The Many Faces of IKZF1 in B-Cell Precursor Acute Lymphoblastic Leukemia","volume":"103","author":"Marke","year":"2018","journal-title":"Haematologica"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1182\/blood.2019000813","article-title":"IKZF1 Deletions in Pediatric Acute Lymphoblastic Leukemia: Still a Poor Prognostic Marker?","volume":"135","author":"Stanulla","year":"2020","journal-title":"Blood"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood-2013-06-509794","article-title":"IKZF1 Status as a Prognostic Feature in BCR-ABL1\u2013Positive Childhood ALL","volume":"123","author":"Zaliova","year":"2014","journal-title":"Blood"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/leu.2010.87","article-title":"IKZF1 Deletions Predict Relapse in Uniformly Treated Pediatric Precursor B-ALL","volume":"24","author":"Kuiper","year":"2010","journal-title":"Leukemia"},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1002\/cam4.87","article-title":"IKZF1 Deletion Is Associated with a Poor Outcome in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia in Japan","volume":"2","author":"Asai","year":"2013","journal-title":"Cancer Med."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1111\/j.1349-7006.2011.02031.x","article-title":"IKZF1 Deletions Predict a Poor Prognosis in Children with B-Cell Progenitor Acute Lymphoblastic Leukemia: A Multicenter Analysis in Taiwan","volume":"102","author":"Yang","year":"2011","journal-title":"Cancer Sci."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/gcc.22245","article-title":"Cooperative Genetic Changes in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia with Deletions or Mutations of IKZF1: Pediatric BCP All with IKZF1 Aberrations","volume":"54","author":"Olsson","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/leu.2012.155","article-title":"Prognostic Value of Genetic Alterations in Children with First Bone Marrow Relapse of Childhood B-Cell Precursor Acute Lymphoblastic Leukemia","volume":"27","author":"Krentz","year":"2013","journal-title":"Leukemia"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.3324\/haematol.2012.075432","article-title":"What Is the Relevance of Ikaros Gene Deletions as a Prognostic Marker in Pediatric Philadelphia-Negative B-Cell Precursor Acute Lymphoblastic Leukemia?","volume":"98","author":"Palmi","year":"2013","journal-title":"Haematologica"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1200\/JCO.2017.74.3617","article-title":"IKZF1plus Defines a New Minimal Residual Disease\u2013Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia","volume":"36","author":"Stanulla","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.ccr.2013.10.022","article-title":"Direct Reversal of Glucocorticoid Resistance by AKT Inhibition in Acute Lymphoblastic Leukemia","volume":"24","author":"Piovan","year":"2013","journal-title":"Cancer Cell"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/jcp.26135","article-title":"Phosphatidylinositol 3-Kinase Inhibition Potentiates Glucocorticoid Response in B-Cell Acute Lymphoblastic Leukemia","volume":"233","author":"Evangelisti","year":"2018","journal-title":"J. Cell Physiol."},{"key":"ref_208","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/leu.2013.277","article-title":"An Intragenic ERG Deletion Is a Marker of an Oncogenic Subtype of B-Cell Precursor Acute Lymphoblastic Leukemia with a Favorable Outcome despite Frequent IKZF1 Deletions","volume":"28","author":"Clappier","year":"2014","journal-title":"Leukemia"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/leu.2013.282","article-title":"ERG Deletion Is Associated with CD2 and Attenuates the Negative Impact of IKZF1 Deletion in Childhood Acute Lymphoblastic Leukemia","volume":"28","author":"Zaliova","year":"2014","journal-title":"Leukemia"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.leukres.2010.11.015","article-title":"Epigenetic Regulation of PAX5 Expression in Acute T-Cell Lymphoblastic Leukemia","volume":"35","author":"Kaiser","year":"2011","journal-title":"Leukemia Res."},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2141.2007.06731.x","article-title":"Identification of PML as Novel PAX5 Fusion Partner in Childhood Acute Lymphoblastic Leukaemia","volume":"139","author":"Nebral","year":"2007","journal-title":"Br. J. Haematol."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2006.06.024","article-title":"PAX Genes: Roles in Development, Pathophysiology, and Cancer","volume":"73","author":"Lang","year":"2007","journal-title":"Biochem. Pharmacol."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1182\/blood-2006-03-009670","article-title":"Oncogenic Role of Pax5 in the T-Lymphoid Lineage upon Ectopic Expression from the Immunoglobulin Heavy-Chain Locus","volume":"109","author":"Souabni","year":"2007","journal-title":"Blood"},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/B978-0-12-385991-4.00005-2","article-title":"Pax5","volume":"Volume 111","author":"Medvedovic","year":"2011","journal-title":"Advances in Immunology"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s12032-014-0360-6","article-title":"The Role of Pax5 in Leukemia: Diagnosis and Prognosis Significance","volume":"32","author":"Shahjahani","year":"2015","journal-title":"Med. Oncol."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1038\/leu.2009.135","article-title":"PAX5 Mutations Occur Frequently in Adult B-Cell Progenitor Acute Lymphoblastic Leukemia and PAX5 Haploinsufficiency Is Associated with BCR-ABL1 and TCF3-PBX1 Fusion Genes: A GRAALL Study","volume":"23","author":"Familiades","year":"2009","journal-title":"Leukemia"},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/bies.20725","article-title":"Losing B Cell Identity","volume":"30","author":"Carotta","year":"2008","journal-title":"Bioessays"},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1182\/blood-2015-02-626127","article-title":"PAX5 Is a Tumor Suppressor in Mouse Mutagenesis Models of Acute Lymphoblastic Leukemia","volume":"125","author":"Dang","year":"2015","journal-title":"Blood"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ebiom.2016.04.038","article-title":"Genomic Profiling of Adult and Pediatric B-Cell Acute Lymphoblastic Leukemia","volume":"8","author":"Liu","year":"2016","journal-title":"EBioMedicine"},{"key":"ref_220","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/leu.2008.306","article-title":"Incidence and Diversity of PAX5 Fusion Genes in Childhood Acute Lymphoblastic Leukemia","volume":"23","author":"Nebral","year":"2009","journal-title":"Leukemia"},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1182\/blood-2006-05-025221","article-title":"A Novel PAX5-ELN Fusion Protein Identified in B-Cell Acute Lymphoblastic Leukemia Acts as a Dominant Negative on Wild-Type PAX5","volume":"109","author":"Bousquet","year":"2007","journal-title":"Blood"},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1182\/blood.V110.11.981.981","article-title":"Rearrangement and Deletion of the PAX5 Gene in Pediatric Acute B-Cell Lineage Lymphoblastic Leukemia","volume":"110","author":"Kawamata","year":"2007","journal-title":"Blood"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1038\/s41375-019-0430-z","article-title":"PAX5 Biallelic Genomic Alterations Define a Novel Subgroup of B-Cell Precursor Acute Lymphoblastic Leukemia","volume":"33","author":"Bastian","year":"2019","journal-title":"Leukemia"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood-2018-10-882142","article-title":"PAX5 P80R Mutation Identifies a Novel Subtype of B-Cell Precursor Acute Lymphoblastic Leukemia with Favorable Outcome","volume":"133","author":"Passet","year":"2019","journal-title":"Blood"},{"key":"ref_225","doi-asserted-by":"crossref","unstructured":"Rehn, J.A., O\u2019Connor, M.J., White, D.L., and Yeung, D.T. (2020). DUX Hunting\u2014Clinical Features and Diagnostic Challenges Associated with DUX4-Rearranged Leukaemia. Cancers, 12.","DOI":"10.3390\/cancers12102815"},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"St. Jude Children\u2019s Research Hospital, Washington University Pediatric Cancer Genome Project, Zhang, J., McCastlain, K., Yoshihara, H., Xu, B., Chang, Y., Churchman, M.L., Wu, G., Li, Y., and Wei, L. (2016). Deregulation of DUX4 and ERG in Acute Lymphoblastic Leukemia. Nat. Genet., 48, 1481\u20131489.","DOI":"10.1038\/ng.3691"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"e352","DOI":"10.3324\/haematol.2018.214353","article-title":"CD371 Cell Surface Expression: A Unique Feature of DUX4 -Rearranged Acute Lymphoblastic Leukemia","volume":"104","author":"Schinnerl","year":"2019","journal-title":"Haematologica"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ng.3535","article-title":"Recurrent DUX4 Fusions in B Cell Acute Lymphoblastic Leukemia of Adolescents and Young Adults","volume":"48","author":"Yasuda","year":"2016","journal-title":"Nat. Genet."},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.3324\/haematol.2018.204487","article-title":"ERG Deletions in Childhood Acute Lymphoblastic Leukemia with DUX4 Rearrangements Are Mostly Polyclonal, Prognostically Relevant and Their Detection Rate Strongly Depends on Screening Method Sensitivity","volume":"104","author":"Zaliova","year":"2019","journal-title":"Haematologica"},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1128\/MCB.20.5.1649-1658.2000","article-title":"CIZ, a Zinc Finger Protein That Interacts with P130 cas and Activates the Expression of Matrix Metalloproteinases","volume":"20","author":"Nakamoto","year":"2000","journal-title":"Mol. Cell Biol."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1038\/sj.leu.2403842","article-title":"CIZ Gene Rearrangements in Acute Leukemia: Report of a Diagnostic FISH Assay and Clinical Features of Nine Patients","volume":"19","author":"Aventin","year":"2005","journal-title":"Leukemia"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/s41586-018-0436-0","article-title":"The Genetic Basis and Cell of Origin of Mixed Phenotype Acute Leukaemia","volume":"562","author":"Alexander","year":"2018","journal-title":"Nature"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1002\/pbc.26116","article-title":"Frequency and Outcome of Pediatric Acute Lymphoblastic Leukemia with ZNF384 Gene Rearrangements Including a Novel Translocation Resulting in an ARID1B\/ZNF384 Gene Fusion","volume":"63","author":"Shago","year":"2016","journal-title":"Pediatr. Blood Cancer"},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"a034835","DOI":"10.1101\/cshperspect.a034835","article-title":"The Biology of B-Progenitor Acute Lymphoblastic Leukemia","volume":"10","author":"Roberts","year":"2020","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_235","doi-asserted-by":"crossref","unstructured":"From the Tokyo Children\u2019s Cancer Study Group, Gocho, Y., Kiyokawa, N., Ichikawa, H., Nakabayashi, K., Osumi, T., Ishibashi, T., Ueno, H., Terada, K., and Oboki, K. (2015). A Novel Recurrent EP300\u2013ZNF384 Gene Fusion in B-Cell Precursor Acute Lymphoblastic Leukemia. Leukemia, 29, 2445\u20132448.","DOI":"10.1038\/leu.2015.111"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1038\/s41375-021-01199-0","article-title":"Clinical Characteristics and Outcomes of B-ALL with ZNF384 Rearrangements: A Retrospective Analysis by the Ponte Di Legno Childhood ALL Working Group","volume":"35","author":"Hirabayashi","year":"2021","journal-title":"Leukemia"},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/714964","article-title":"Renal and Hematological Effects of CLCF-1, a B-Cell-Stimulating Cytokine of the IL-6 Family","volume":"2015","author":"Savin","year":"2015","journal-title":"J. Immunol. Res."},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.exphem.2016.04.011","article-title":"Comprehensive Genomic Analysis Reveals FLT3 Activation and a Therapeutic Strategy for a Patient with Relapsed Adult B-Lymphoblastic Leukemia","volume":"44","author":"Griffith","year":"2016","journal-title":"Exp. Hematol."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/76923","article-title":"Cloning of a Receptor Subunit Required for Signaling by Thymic Stromal Lymphopoietin","volume":"1","author":"Pandey","year":"2000","journal-title":"Nat. Immunol."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1038\/sj.onc.1203486","article-title":"STAT Signaling in the Pathogenesis and Treatment of Leukemias","volume":"19","author":"Lin","year":"2000","journal-title":"Oncogene"},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1038\/leu.2012.84","article-title":"Outcome in Children with Down\u2019s Syndrome and Acute Lymphoblastic Leukemia: Role of IKZF1 Deletions and CRLF2 Aberrations","volume":"26","author":"Buitenkamp","year":"2012","journal-title":"Leukemia"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.1182\/blood-2009-03-208397","article-title":"Deregulated Expression of Cytokine Receptor Gene, CRLF2, Is Involved in Lymphoid Transformation in B-Cell Precursor Acute Lymphoblastic Leukemia","volume":"114","author":"Russell","year":"2009","journal-title":"Blood"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"96466","DOI":"10.18632\/oncotarget.22098","article-title":"The Enigmatic Role(s) of P2RY8-CRLF2","volume":"8","author":"Haas","year":"2017","journal-title":"Oncotarget"},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/gcc.22190","article-title":"An Overall Characterization of Pediatric Acute Lymphoblastic Leukemia with CRLF2 Overexpression: Prognostic Significance of CRLF2 Overexpression in Pediatric All","volume":"53","author":"Yano","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1182\/blood-2009-09-245944","article-title":"Rearrangement of CRLF2 Is Associated with Mutation of JAK Kinases, Alteration of IKZF1, Hispanic\/Latino Ethnicity, and a Poor Outcome in Pediatric B-Progenitor Acute Lymphoblastic Leukemia","volume":"115","author":"Harvey","year":"2010","journal-title":"Blood"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/gcc.22439","article-title":"Characterisation of the Genomic Landscape of CRLF2-rearranged Acute Lymphoblastic Leukemia","volume":"56","author":"Russell","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1038\/leu.2012.101","article-title":"Poor Prognosis for P2RY8-CRLF2 Fusion but Not for CRLF2 over-Expression in Children with Intermediate Risk B-Cell Precursor Acute Lymphoblastic Leukemia","volume":"26","author":"Palmi","year":"2012","journal-title":"Leukemia"},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1182\/blood-2009-11-256131","article-title":"Presence of the P2RY8-CRLF2 Rearrangement Is Associated with a Poor Prognosis in Non\u2013High-Risk Precursor B-Cell Acute Lymphoblastic Leukemia in Children Treated According to the ALL-BFM 2000 Protocol","volume":"115","author":"Cario","year":"2010","journal-title":"Blood"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1200\/JCO.2013.51.3242","article-title":"IGH @ Translocations Are Prevalent in Teenagers and Young Adults with Acute Lymphoblastic Leukemia and Are Associated with a Poor Outcome","volume":"32","author":"Russell","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood-2009-05-218560","article-title":"Gene Expression Classifiers for Relapse-Free Survival and Minimal Residual Disease Improve Risk Classification and Outcome Prediction in Pediatric B-Precursor Acute Lymphoblastic Leukemia","volume":"115","author":"Kang","year":"2010","journal-title":"Blood"},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1182\/blood-2011-12-389932","article-title":"Aberrant STAT5 and PI3K\/MTOR Pathway Signaling Occurs in Human CRLF2-Rearranged B-Precursor Acute Lymphoblastic Leukemia","volume":"120","author":"Tasian","year":"2012","journal-title":"Blood"},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1242\/dev.008367","article-title":"MEF2: A Central Regulator of Diverse Developmental Programs","volume":"134","author":"Potthoff","year":"2007","journal-title":"Development"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"13331","DOI":"10.1038\/ncomms13331","article-title":"Genomic Analyses Identify Recurrent MEF2D Fusions in Acute Lymphoblastic Leukaemia","volume":"7","author":"Gu","year":"2016","journal-title":"Nat. Commun."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3324\/haematol.2017.186320","article-title":"Clinical and Molecular Characteristics of MEF2D Fusion-Positive B-Cell Precursor Acute Lymphoblastic Leukemia in Childhood, Including a Novel Translocation Resulting in MEF2D-HNRNPH1 Gene Fusion","volume":"104","author":"Ohki","year":"2019","journal-title":"Haematologica"},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"110330","DOI":"10.1016\/j.biopha.2020.110330","article-title":"Staurosporine and Venetoclax Induce the Caspase-Dependent Proteolysis of MEF2D-Fusion Proteins and Apoptosis in MEF2D-Fusion (+) ALL Cells","volume":"128","author":"Tange","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1101\/gad.267583.115","article-title":"The Oncogenic BRD4-NUT Chromatin Regulator Drives Aberrant Transcription within Large Topological Domains","volume":"29","author":"Alekseyenko","year":"2015","journal-title":"Genes Dev."},{"key":"ref_257","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1038\/s41375-021-01333-y","article-title":"Favorable Outcome of NUTM1-Rearranged Infant and Pediatric B Cell Precursor Acute Lymphoblastic Leukemia in a Collaborative International Study","volume":"35","author":"Boer","year":"2021","journal-title":"Leukemia"},{"key":"ref_258","doi-asserted-by":"crossref","first-page":"e455","DOI":"10.3324\/haematol.2018.206961","article-title":"NUTM1 Is a Recurrent Fusion Gene Partner in B-Cell Precursor Acute Lymphoblastic Leukemia Associated with Increased Expression of Genes on Chromosome Band 10p12.31-12.2","volume":"104","author":"Hormann","year":"2019","journal-title":"Haematologica"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/nrc3659","article-title":"NUT Midline Carcinoma","volume":"14","author":"French","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","article-title":"Cancer Cell Cycles","volume":"274","author":"Sherr","year":"1996","journal-title":"Science"},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1093\/emboj\/17.17.5001","article-title":"The Alternative Product from the Human CDKN2A Locus, P14ARF, Participates in a Regulatory Feedback Loop with P53 and MDM2","volume":"17","author":"Stott","year":"1998","journal-title":"EMBO J."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/08880018.2016.1251518","article-title":"The Role of CDKN2A\/B Deletions in Pediatric Acute Lymphoblastic Leukemia","volume":"33","author":"Vela","year":"2016","journal-title":"Pediatric Hematol. Oncol."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1038\/s41598-019-41078-4","article-title":"Copy Number Alterations in B-Cell Development Genes, Drug Resistance, and Clinical Outcome in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia","volume":"9","author":"Steeghs","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3324\/haematol.2013.085175","article-title":"Genes Commonly Deleted in Childhood B-Cell Precursor Acute Lymphoblastic Leukemia: Association with Cytogenetics and Clinical Features","volume":"98","author":"Schwab","year":"2013","journal-title":"Haematologica"},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1080\/10428194.2018.1482542","article-title":"Deletion of CDKN2A\/B Is Associated with Inferior Relapse Free Survival in Pediatric B Cell Acute Lymphoblastic Leukemia","volume":"60","author":"Kathiravan","year":"2019","journal-title":"Leuk. Lymphoma"},{"key":"ref_266","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1080\/07853890.2018.1564359","article-title":"Prognostic Significance of CDKN2A\/B Deletions in Acute Lymphoblastic Leukaemia: A Meta-Analysis","volume":"51","author":"Zhang","year":"2019","journal-title":"Ann. Med."},{"key":"ref_267","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Gil, C., Ribera, J., Ribera, J.M., and Genesc\u00e0, E. (2021). The Yin and Yang-Like Clinical Implications of the CDKN2A\/ARF\/CDKN2B Gene Cluster in Acute Lymphoblastic Leukemia. Genes, 12.","DOI":"10.3390\/genes12010079"},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ccr.2012.09.016","article-title":"Therapeutic Targeting of the Cyclin D3:CDK4\/6 Complex in T Cell Leukemia","volume":"22","author":"Sawai","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"5320","DOI":"10.1158\/1078-0432.CCR-13-0259","article-title":"The Cell-Cycle Regulator CDK4: An Emerging Therapeutic Target in Melanoma","volume":"19","author":"Sheppard","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1158\/1078-0432.CCR-13-1551","article-title":"Molecular Pathways: CDK4 Inhibitors for Cancer Therapy","volume":"20","author":"Dickson","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/gcc.2870130109","article-title":"Dic(9;20): A New Recurrent Chromosome Abnormality in Adult Acute Lymphoblastic Leukemia","volume":"13","author":"Rieder","year":"1995","journal-title":"Genes. Chromosomes Cancer"},{"key":"ref_272","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1038\/sj.leu.2401654","article-title":"Monosomy 20 as a Pointer to Dicentric (9;20) in Acute Lymphoblastic Leukemia","volume":"14","author":"Clark","year":"2000","journal-title":"Leukemia"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/gcc.20517","article-title":"Clinical and Cytogenetic Features of Pediatric Dic(9;20)(P13.2;Q11.2)-Positive B-Cell Precursor Acute Lymphoblastic Leukemias: A Nordic Series of 24 Cases and Review of the Literature","volume":"47","author":"Forestier","year":"2008","journal-title":"Genes. Chromosomes Cancer"},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/leu.2013.189","article-title":"Detecting Dic(9;20)(P13.2;P11.2)-Positive B-Cell Precursor Acute Lymphoblastic Leukemia in a Clinical Setting Using Fluorescence in Situ Hybridization","volume":"28","author":"Zachariadis","year":"2014","journal-title":"Leukemia"},{"key":"ref_275","unstructured":"Mitelman, F., Johansson, B., and Mertens, F. (2022, January 29). Mitelman Database of Chromosome Aberrations and Gene Fusions in Cancer. Available online: https:\/\/mitelmandatabase.isb-cgc.org."},{"key":"ref_276","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1080\/07853890410018808","article-title":"Clinical and Biological Importance of Cytogenetic Abnormalities in Childhood and Adult Acute Lymphoblastic Leukemia","volume":"36","author":"Johansson","year":"2004","journal-title":"Ann. Med."},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.3324\/haematol.2008.002808","article-title":"Heterogeneous Breakpoints in Patients with Acute Lymphoblastic Leukemia and the Dic(9;20)(P11~13;Q11) Show Recurrent Involvement of Genes at 20q11.21","volume":"94","author":"An","year":"2009","journal-title":"Haematologica"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1365-2141.2006.06328.x","article-title":"Characterisation of Dic(9;20)(P11-13;Q11) in Childhood B-Cell Precursor Acute Lymphoblastic Leukaemia by Tiling Resolution Array-Based Comparative Genomic Hybridisation Reveals Clustered Breakpoints at 9p13.2 and 20q11.2","volume":"135","author":"Schoumans","year":"2006","journal-title":"Br. J. Haematol."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1038\/sj.onc.1210190","article-title":"Genome Complexity in Acute Lymphoblastic Leukemia Is Revealed by Array-Based Comparative Genomic Hybridization","volume":"26","author":"Strefford","year":"2007","journal-title":"Oncogene"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1365-2141.2009.08059.x","article-title":"Prognostic Relevance of Dic(9;20)(P11;Q13) in Childhood B-Cell Precursor Acute Lymphoblastic Leukaemia Treated with Berlin-Frankfurt-M\u00fcnster (BFM) Protocols Containing an Intensive Induction and Post-Induction Consolidation Therapy","volume":"149","author":"Pichler","year":"2010","journal-title":"Br. J. Haematol."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/leu.2008.179","article-title":"Dic(9;20)(P13;Q11) in Childhood Acute Lymphoblastic Leukaemia Is Related to Low Cellular Resistance to Asparaginase, Cytarabine and Corticosteroids","volume":"23","author":"Nordgren","year":"2009","journal-title":"Leukemia"},{"key":"ref_282","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3389\/fped.2017.00258","article-title":"Integration of Next-Generation Sequencing to Treat Acute Lymphoblastic Leukemia with Targetable Lesions: The St. Jude Children\u2019s Research Hospital Approach","volume":"5","author":"Inaba","year":"2017","journal-title":"Front. Pediatr."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/5\/2755\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:30:46Z","timestamp":1760135446000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/5\/2755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,2]]},"references-count":282,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,3]]}},"alternative-id":["ijms23052755"],"URL":"https:\/\/doi.org\/10.3390\/ijms23052755","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,2]]}}}